TD Private Client Wealth’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-34
| Closed | -$947 | – | 1294 |
|
|
2021
Q3 | $947 | Hold |
34
| – | – | ﹤0.01% | 1114 |
|
|
2021
Q2 | $1.01K | Hold |
34
| – | – | ﹤0.01% | 1109 |
|
|
2021
Q1 | $950 | Hold |
34
| – | – | ﹤0.01% | 1077 |
|
|
2020
Q4 | $964 | Hold |
34
| – | – | ﹤0.01% | 1022 |
|
|
2020
Q3 | $855 | Hold |
34
| – | – | ﹤0.01% | 980 |
|
|
2020
Q2 | $830 | Hold |
34
| – | – | ﹤0.01% | 974 |
|
|
2020
Q1 | $503 | Hold |
34
| – | – | ﹤0.01% | 965 |
|
|
2019
Q4 | $552 | Buy |
+34
| New | +$552 | ﹤0.01% | 983 |
|